RMC-9945
RMC-9945 (RM-044) is a KRAS inhibitor that is selective, covalent, and orally active against the RAS (ON) G12D mutation. It enhances the transcriptional activity of β-Catenin/TCF and demonstrates sustained disease control in early liver metastasis models of colorectal cancer.
Product Specifications
CAS Number
2922732-38-3
Smiles
O=C1OCC (C) (C) CC=2C3=CC (=CC=C3N (C2C4=CC (=CN=C4C (OC) C) N5CCN (CC5) C6CC6) CC (F) (F) F) C=7N=C (SC7) CC (NC (=O) C (N8CCC9 (CN (C (=O) C%10N (C) C%10C%11CC%11) CC9) C8) C (C) C) C (=O) N%12NC1CCC%12
Molecular Formula
C60H80F3N11O6S
Molecular Weight
1140.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402366-100 1x 100 µL
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682027-500 1x 500 µL
CD45 / LCA (Leucocyte Marker) (PTPRC/1147 + PTPRC/1460), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 